期刊文献+

大鼠急性铀中毒的螯合剂治疗 被引量:4

EFFICACY OF CHELATNG AGENTS FOR TREATMENT OF ACUTE URANIUM INTOXICATION IN RATS
下载PDF
导出
摘要 本文比较了几种螯合利(8102、7601、811、7603、8307、DTPA)对大鼠急性铀中毒的治疗效果。结果表明.肌肉注射500mg/kg螯合剂.除DTPA外均有明显的促排铀效果,表现为尿铀排出量增加,肾铀蓄积量降低.其中以8102效果最好;8102不同时间给药(中毒前1h至中毒后48h),观察到中毒前1h,中毒后立即及中毒后1h给药均有明显的促排铀效果;8102对铀所致肾脏损伤的病理改善,以中毒前1h给药组最佳。此时仅见肾曲管上皮细胞轻度水样变性。 Chelating agents,(8102,7601,811,7603,8307,DTPA)were tested for treatmentof acute uraniurn intoxication in rats, All phenolic chelating agents distinctively increased removal of uranium when thev were injected immediately after intoxication of uranyl nitrate. 8102 was the best of them on removing uranium. After a single i.m. injection of 8102 at doseof 500 mg/kg,the excretion of uranium in the urine was 2.9 times higher than that for control,and the retention of uranium in kidneys was their 29%. When 8102 was administered 1hbefore and up to 4 h after intoxication, it markedly increased the removal of uranium. When8102 was administered to rats 1h before intoxication,the histological lesion in kidneys was only a slight hydropic degeneration of the tubule epithelial cells. On the contrary,there was asevere necrosis of the tubule epithelial cells in kidneys for controls.
出处 《辐射防护》 CAS CSCD 北大核心 1995年第3期186-189,共4页 Radiation Protection
关键词 螯合剂 肾曲管 坏死 大鼠 中毒 Chelating Agent,8102,Uranium,Necrosis of Renal Tubule,Rats
  • 相关文献

参考文献8

  • 1罗梅初,陈桂宝.苯酚类螯合剂对铀中毒的解毒和排铀效果[J].中华放射医学与防护杂志,1992,12(5):312-315. 被引量:9
  • 2沈彬源,辐射防护,1988年,8卷,1期,25页
  • 3陶正琴,中国药理学报,1987年,8卷,3期,284页
  • 4苏昆源,中华放射医学与防护杂志,1985年,5卷,6期,402页
  • 5孙世荃,中华放射医学与防护杂志,1985年,5卷,6期,392页
  • 6赵兴成,辐射防护,1982年,2卷,2期,127页
  • 7范积雄,辐射防护,1981年,1卷,4期,49页
  • 8赵兴成,中华放射医学与防护杂志,1980年,4期,49页

共引文献8

同被引文献19

  • 1刘实晶,罗梅初,陈桂宝,张美珍,孙梅贞.小剂量8102对大鼠急性铀中毒的促排效果[J].上海医科大学学报,1996,23(4):275-277. 被引量:9
  • 2沈彬源,辐射防护,1988年,8卷,1期,25页
  • 3阮天明,辐射防护,1987年,7卷,1期,60页
  • 4朱寿彭,李章. 铀及铀系主要核素的放射毒理学. 放射毒理学. 2版. 北京: 原子能出版社, 1992: 222-298.
  • 5Durbin PW, Kullgren B, Ebbe SN, et al. Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice. Health Phys, 2000,78 (5):511-521.
  • 6Paquet F, Chazel V, Houpert P, et al. Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOX. Radiat Prot Dosimetry, 2003,105 (1-4):521-525.
  • 7Abergel RJ, Durbin PW, Kullgren B, et al. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO). Health Phys, 2010,99 (3):401-407.
  • 8Bergeron RJ, Wiegand J, Singh S. Desferrithiocin analogue uranium decorporation agents. Int J Radiat Biol, 2009,85 (4):348-361.
  • 9Zhang XF, Ding CL, Liu H, et al. Protective effects of ion-imprinted chitooligosaccharides as uranium-specific chelating agents against the cytotoxicity of depleted uranium in human kidney cells. Toxicology, 2011,286 (1-3):75-84.
  • 10胡南,张新华,黄爱武,王永东,李广悦,郑济芳,丁德馨.铀尾矿浸出液对斑马鱼组织某些生化指标的研究[J].毒理学杂志,2008,22(3):207-209. 被引量:1

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部